Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2575909 | The American Journal of Geriatric Pharmacotherapy | 2009 | 7 Pages |
Abstract
Conclusions: In this decision analysis, genotype-guided warfarin therapy for anticoagulation in elderly patients with AF was potentially cost-effective, and its benefits were closely related to efficacy in preventing bleeding events. Clinical trials testing the efficacy of genotype-guided warfarin therapy are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Julio A. MD, MSc, Steve MD, MSc, Jennifer A. MD, Toni P. MD, PhD,